Vaccine News and Research

Latest Vaccine News and Research

Are pan-coronavirus vaccines an achievable goal in providing broad protection against human coronaviruses?

The current achievements in the development of a pan-coronavirus vaccine.

3 Jan 2024

Hybrid immunity's role in curbing COVID-19: Canadian study sheds light on vaccine-infection synergy

Study evaluates the impact of hybrid immunity on SARS-CoV-2 antibody levels in Canadian adults, revealing that hybrid immunity, combining vaccination and recovery from infection, significantly reduces COVID-19 morbidity and mortality.

2 Jan 2024

New Pfizer/BioNTech vaccine variant shows enhanced protection against COVID-19 hospitalization

Study demonstrates that the BNT162b2 SARS-CoV-2 XBB1.5 variant-modified vaccine significantly reduces the risk of COVID-19-related hospitalizations and ambulatory visits, outperforming previous vaccine versions in the face of evolving virus strains.

2 Jan 2024

RSV vaccines would dramatically reduce disease burden if widely adopted like flu shots

Respiratory syncytial virus (RSV) vaccines recently approved for people 60 and older would dramatically reduce the disease's significant burden of illness and death in the United States if they were widely adopted like annual influenza vaccines, a new study has found.

2 Jan 2024

Exploring the global health challenge of hepatitis D

Review explores the global impact of the hepatitis D virus (HDV) on public health, detailing its transmission, clinical course, diagnosis, and treatment options.

2 Jan 2024

Microbial decoration enhances drug delivery specificity and safety

Announcing a new publication for Acta Materia Medica journal. Microorganisms are mostly distributed on the surface of our skin and intestines and have crucial roles in physiologic and metabolic processes, such as digestion and immunity, which are closely related to diseases.

29 Dec 2023

Attitudes toward pet vaccination may be linked with human vaccine hesitancy

Texas A&M University School of Public Health research on attitudes toward pet vaccination and how they may be linked with human vaccine hesitancy was the subject of a new study recently published in the journal Vaccine.

25 Dec 2023

Previously unrecognized class of antibodies can broadly neutralize multiple virus strains

Researchers have identified a previously unrecognized class of antibodies - immune system proteins that protect against disease - that appear capable of neutralizing multiple forms of flu virus.

21 Dec 2023

Study reveals how measles virus mutates and spreads in the human brain

Mayo Clinic researchers mapped how the measles virus mutated and spread in the brain of a person who succumbed to a rare, lethal brain disease.

21 Dec 2023

R21/Matrix-M vaccine gets WHO green light for global rollout

The R21/Matrix-M™ malaria vaccine is one step closer to mass rollout, after officially receiving WHO prequalification status, making it eligible for procurement by United Nations agencies.

21 Dec 2023

UKHSA and ONS publish latest Winter CIS data

The Winter CIS was launched jointly by the UK Health Security Agency (UKHSA) and the Office for National Statistics (ONS) in November 2023 to deliver real-time prevalence and positivity data to aid the surveillance of COVID-19 in the community and help understand the winter pressures on the NHS.

21 Dec 2023

New vaccine design targets universal immunity with "chef"-inspired tool

Vaccine development aims at protecting as many people as possible from infections. Short protein fragments of pathogens, so-called epitopes, are seen as a promising new approach for vaccine development.

20 Dec 2023

Over 1 million deaths linked to antimicrobial resistance in Africa

Over 1.05 million deaths were associated with antimicrobial resistance (AMR) and 250,000 deaths were attributable to AMR in the WHO African region, posing an unprecedented health threat.

19 Dec 2023

Autopsy study provides new insights into yellow fever's impact on the heart

To fill gaps in knowledge of yellow fever (YF), a group of researchers in Brazil affiliated with the Department of Pathology at the University of São Paulo's Medical School (FM-USP), Hospital das Clínicas (HC, the hospital complex run by FM-USP), the Heart Institute (InCor, linked to HC) and Emílio Ribas Institute of Infectious Diseases (IIER) decided to study the pathogenesis of YF-associated heart injury.

19 Dec 2023

New vaccine could offer affordable hope for millions with high cholesterol

Nearly two in five U.S. adults have high cholesterol, according to the Centers for Disease Control and Prevention (CDC). Untreated, high cholesterol can lead to heart disease and stroke, which are two of the top causes of death in the U.S. Worldwide;, cardiovascular diseases claim nearly 18 million lives every year, according to the World Health Organization.

19 Dec 2023

Two new practice parameters offer recommendations for treating anaphylaxis and atopic dermatitis

Two new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis (AD) in pediatric and adult patients.

18 Dec 2023

New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

Study presents a new SARS-CoV-2 S2 subunit vaccine that elicits strong antibody responses against various sarbecovirus strains, including challenging variants like XBB.1.5, demonstrating its potential as a broadly effective and stable vaccine option.

18 Dec 2023

€7.4M EU grant boosts development of vaccines against Marburg viruses

International research consortium receives highly endowed Horizon Europe funding for the development of vaccines against Marburg viruses.

18 Dec 2023

People feel more impatient just before reaching the finish line, study says

A new study answers a timely question: What is the hardest part of waiting? Consumers do plenty of it - online, in line, in traffic, or for deliveries. And now we know it's the final phase that's most problematic for them.

18 Dec 2023

New study shows XBB.1.5 COVID-19 vaccine significantly reduces hospitalizations and ICU admissions in older adults

Study evaluates the effectiveness of the XBB.1.5 COVID-19 vaccine in reducing hospitalizations and ICU admissions among vaccinated adults aged 60 and over in the Netherlands, showing a 70.7% effectiveness against hospitalization and 73.3% against ICU admission.

17 Dec 2023